companydata.dkcompanydata.dk

ORIFARM GENERICS HOLDING A/S: Financial statements 2013

CVR: 27347223

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 6,792,000 and a net result of DKK -150,000 compared with DKK 7,089,000 the year before. That is a decrease of 48.2% compared with the year before. Equity in the 2013 report amounted to DKK 11,543,000. The solvency ratio was 23.1%.

Gross Profit
DKK 6,792,000
Profit/Loss
DKK -150,000
Equity
DKK 11,543,000
Total Assets
DKK 50,050,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013-6.8M-150K11.5M-
2012-13.1M7.1M12M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

ORIFARM GENERICS HOLDING A/S: The 2012 annual report is outJun 1, 2013

ORIFARM GENERICS HOLDING A/S has published its annual report for 2012. Gross profit came to DKK 13,109,000, and the net result was DKK 7,089,000.

Hans Christian Eberhard Groth Teisen joins the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Hans Christian Eberhard Groth Teisen has joined the board of directors of ORIFARM GENERICS HOLDING A/S.

Hans Carl Bøgh-Sørensen joins the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Hans Carl Bøgh-Sørensen has joined the board of directors of ORIFARM GENERICS HOLDING A/S.

Erik Sandberg joins the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Erik Sandberg has joined the board of directors of ORIFARM GENERICS HOLDING A/S.

Peter Arend William Burema joins the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Peter Arend William Burema has joined the board of directors of ORIFARM GENERICS HOLDING A/S.

Jean-Francois Loumeau joins the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Jean-Francois Loumeau has joined the board of directors of ORIFARM GENERICS HOLDING A/S.

Ole Michael Friis leaves the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Ole Michael Friis has left the board of directors of ORIFARM GENERICS HOLDING A/S.

Claus Christian Bayer leaves the board of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Claus Christian Bayer has left the board of directors of ORIFARM GENERICS HOLDING A/S.

Ulrik Ernst Rasmussen joins ORIFARM GENERICS HOLDING A/S as adm. dir.Mar 4, 2013

As of March 4, 2013, Ulrik Ernst Rasmussen is registered as adm. dir. of ORIFARM GENERICS HOLDING A/S.

Hans Carl Bøgh-Sørensen steps down as adm. dir. of ORIFARM GENERICS HOLDING A/SMar 4, 2013

As of March 4, 2013, Hans Carl Bøgh-Sørensen has stepped down as adm. dir. of ORIFARM GENERICS HOLDING A/S.

About ORIFARM GENERICS HOLDING A/S

ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.

Source: annual report 2025, Danish Business Authority